data_1j4q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j4q _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.838 0.351 . . . . 10.109999999999999 110.956 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.81 14.08 9.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 11.27 111.327 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -47.24 50.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.817 0.341 . . . . 12.98 110.991 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -67.1 -52.35 43.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 11.02 110.935 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.41 -35.48 70.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 7.6299999999999999 110.252 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.08 -35.42 71.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.518 . . . . 10.289999999999999 110.005 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' HA ' ' CD2' ' A' ' 23' ' ' PHE . 4.1 mt -64.32 -48.18 86.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.88 -0.6 . . . . 9.7599999999999998 110.142 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.67 -33.39 72.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.402 -0.817 . . . . 6.8700000000000001 111.074 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -64.72 -46.66 81.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 8.5 111.982 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.491 ' CG ' ' N ' ' A' ' 24' ' ' SER . 1.6 p90 -71.21 -48.86 48.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.949 0.404 . . . . 13.43 111.143 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.491 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 3.7 m -58.08 -38.03 75.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.832 -0.622 . . . . 10.6 110.791 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 179.15 88.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 11.35 110.944 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.63 154.93 27.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 10.66 110.363 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.99 100.4 2.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.382 . . . . 8.6899999999999995 110.662 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.3 mm -105.58 140.46 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.559 0.695 . . . . 8.4000000000000004 111.838 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.93 -0.05 9.08 Favored Glycine 0 C--N 1.316 -0.554 0 CA-C-N 114.775 -1.102 . . . . 7.4800000000000004 112.915 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.36 -35.91 40.74 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.968 0.413 . . . . 8.8000000000000007 110.64 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.1 m-20 -177.19 32.94 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.977 -1.12 . . . . 6.4000000000000004 107.977 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 10.6 mm -90.84 120.26 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 CA-C-N 113.813 -1.539 . . . . 6.1200000000000001 111.47 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.499 ' CG2' ' HA ' ' A' ' 49' ' ' SER . 1.9 t -85.58 -66.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 115.135 -0.939 . . . . 4.1699999999999999 110.953 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.8 p -147.72 157.56 43.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.892 -0.594 . . . . 3.8199999999999998 110.838 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.94 138.17 53.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.333 -0.394 . . . . 7.5700000000000003 111.068 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.434 HG21 ' CD1' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -106.4 122.68 60.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.855 0.36 . . . . 4.4000000000000004 111.148 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.07 124.05 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.077 -0.51 . . . . 5.9400000000000004 111.492 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 44.2 t -81.19 124.82 29.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.555 -0.293 . . . . 5.2400000000000002 110.555 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.14 -25.88 18.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.453 -0.339 . . . . 6.2000000000000002 111.516 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.435 HG22 ' HB3' ' A' ' 142' ' ' SER . 64.3 p -79.82 -2.57 43.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 5.2300000000000004 111.468 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.93 74.8 0.41 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.982 -0.628 . . . . 5.7300000000000004 113.095 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -145.38 -42.57 0.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 4.79 111.044 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.537 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 2.5 mt -115.45 140.86 26.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 4.9100000000000001 110.897 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.537 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.3 Cg_endo -72.53 143.72 38.9 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.155 1.903 . . . . 6.2699999999999996 112.164 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mt -58.09 143.43 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 6.79 111.634 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -135.94 164.1 28.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.643 -0.708 . . . . 6.7300000000000004 109.991 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.86 119.55 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 6.5 111.925 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.554 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 4.2 mt -92.73 137.07 32.68 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.881 -0.785 . . . . 4.3099999999999996 108.881 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.503 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -149.49 158.31 44.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 114.198 1.185 . . . . 5.5800000000000001 114.198 -178.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.77 146.26 32.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.635 -1.62 . . . . 4.6100000000000003 111.053 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.412 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -74.83 125.85 29.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.228 -0.442 . . . . 6.6399999999999997 111.181 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mt -64.57 -42.04 94.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.801 -0.636 . . . . 5.3300000000000001 112.016 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 71.8 m -61.66 -39.93 93.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.339 0.59 . . . . 6.3600000000000003 110.526 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.412 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 24.8 mm-40 -69.22 -36.82 77.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.124 -0.944 . . . . 7.0700000000000003 110.752 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.68 -45.57 87.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.04 -0.527 . . . . 4.3899999999999997 110.884 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 tt -71.08 -41.33 70.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 4.8899999999999997 110.802 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -69.27 -37.63 77.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 8.1500000000000004 110.753 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -82.04 100.09 9.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.201 -0.454 . . . . 5.6399999999999997 110.878 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.04 46.54 1.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 6.9500000000000002 110.861 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -169.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 9.0299999999999994 110.868 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.8 m -67.44 -51.62 49.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 5.3799999999999999 111.009 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 93' ' ' LEU . 9.8 tp -130.45 157.18 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 4.5700000000000003 111.219 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -103.49 -78.44 0.55 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.295 -0.411 . . . . 4.4299999999999997 111.109 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 49' ' ' SER . 8.1 ttpt -128.09 136.2 50.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.398 -0.364 . . . . 5.3700000000000001 111.266 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 5.7 t -125.72 138.64 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.074 0.464 . . . . 3.6099999999999999 111.668 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.554 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 15.9 m-90 -101.54 139.38 37.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.522 -0.763 . . . . 3.9900000000000002 112.127 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -113.73 126.92 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.149 -0.685 . . . . 3.8500000000000001 109.149 177.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.512 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -115.51 145.54 42.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.103 -0.499 . . . . 3.0800000000000001 111.271 -178.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.02 -168.04 36.21 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.576 -0.821 . . . . 3.3300000000000001 112.709 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 4.1 mtp-105 -83.43 4.2 28.69 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.665 0.246 . . . . 5.0899999999999999 111.665 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 8.7 t-20 -84.87 133.66 43.07 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.653 0.263 . . . . 5.75 111.195 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.6 Cg_exo -67.3 -12.87 37.44 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.642 2.228 . . . . 6.3799999999999999 111.779 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.02 -42.79 15.8 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.849 0.833 . . . . 5.8200000000000003 109.051 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.56 136.33 1.87 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.821 -1.536 . . . . 4.6299999999999999 111.178 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.9 m-20 -55.61 -18.42 7.66 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.527 -0.76 . . . . 4.9900000000000002 109.992 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 29.5 t80 -130.74 116.06 17.5 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.375 -0.375 . . . . 4.2999999999999998 110.543 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -99.77 118.97 37.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.895 0.379 . . . . 5.7300000000000004 111.042 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mt -87.11 -167.35 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 4.29 110.614 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.44 -76.49 0.92 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.699 -0.762 . . . . 4.4900000000000002 112.339 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 p30 175.11 78.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 5.5099999999999998 110.81 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.42 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 30.8 mm -110.11 111.3 35.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 3.21 111.311 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 m -55.08 -30.15 59.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 3.73 111.197 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.39 -31.35 70.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.398 -0.365 . . . . 4.3600000000000003 110.862 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.3 mt -88.22 152.01 22.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 2.7599999999999998 110.715 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 p -96.2 160.51 14.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.773 0.286 . . . . 3.4100000000000001 111.773 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.613 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -38.01 -53.28 1.37 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.368 0.604 . . . . 4.9199999999999999 110.001 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -119.71 83.01 1.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.988 -1.486 . . . . 5.2300000000000004 106.988 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.548 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -62.11 -46.17 90.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.115 -0.948 . . . . 2.3100000000000001 112.728 -177.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.7 p90 -145.77 161.34 40.16 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.26 -0.576 . . . . 2.6600000000000001 111.913 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 4.6 tt0 -136.23 142.32 44.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.21 -0.45 . . . . 3.4500000000000002 111.407 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.437 ' O ' ' CG1' ' A' ' 65' ' ' VAL . 60.9 mt -117.33 132.15 67.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 121.109 -0.236 . . . . 2.0699999999999998 110.891 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.57 143.1 44.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.031 0.443 . . . . 3.1499999999999999 111.853 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.409 ' CD1' ' CG1' ' A' ' 33' ' ' VAL . 11.0 tp -125.27 128.46 48.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.796 -0.638 . . . . 3.3799999999999999 110.387 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.07 -129.19 1.98 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.586 -0.816 . . . . 3.1800000000000002 112.557 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.3 -76.25 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.765 0.316 . . . . 5.6500000000000004 110.934 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -158.38 -68.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 4.4500000000000002 110.962 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -148.63 28.37 1.32 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.704 -0.76 . . . . 3.6699999999999999 112.469 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -132.06 -178.06 4.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 4.1399999999999997 110.894 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.405 ' HB2' ' CD2' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -125.48 155.35 40.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 3.2999999999999998 110.87 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.3 mt -133.19 146.65 51.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 3.77 110.357 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.7 127.82 56.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.331 -0.395 . . . . 3.4399999999999999 110.346 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 90' ' ' GLN . 51.0 t30 -118.16 115.2 24.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 3.6899999999999999 111.682 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.671 ' CG ' ' HA ' ' A' ' 118' ' ' LYS . 9.1 p30 -77.16 142.89 39.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.209 -0.45 . . . . 3.75 109.919 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.9 pt -150.26 38.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.028 0.381 . . . . 3.4900000000000002 112.028 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.548 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -99.51 153.63 18.88 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 120.996 0.427 . . . . 3.6400000000000001 111.576 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.1 m -69.83 -32.11 70.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.849 -0.614 . . . . 4.6399999999999997 109.969 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -95.72 -20.67 18.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.824 0.675 . . . . 4.0700000000000003 112.824 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.507 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.99 158.27 10.88 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.395 -0.907 . . . . 3.77 113.357 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.6 m -117.86 138.55 52.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.555 -0.535 . . . . 3.48 109.555 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.853 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.48 149.05 40.16 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.598 0.962 . . . . 5.0599999999999996 113.598 -178.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.38 112.17 16.63 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.671 -1.149 . . . . 4.7999999999999998 108.35 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 44.72 43.21 6.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 5.6799999999999997 112.258 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.17 -11.56 69.11 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.779 -0.724 . . . . 5.6100000000000003 113.483 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -104.64 117.32 33.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.149 0.474 . . . . 6.9000000000000004 110.789 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.3 tptm -72.29 131.44 42.7 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.866 -0.606 . . . . 5.4100000000000001 111.217 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.0 m -103.44 165.36 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 4.9299999999999997 111.308 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 120' ' ' SER . 37.3 tt0 -69.71 125.79 27.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 6.9000000000000004 110.671 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.671 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.9 tttt -53.32 162.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.369 . . . . 4.9699999999999998 110.784 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' ASP . 11.0 m-80 33.89 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.571 -0.74 . . . . 5.3600000000000003 112.351 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -113.67 144.97 42.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.717 -0.674 . . . . 5.3600000000000003 111.01 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -86.66 134.8 33.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 4.4699999999999998 110.934 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 39.5 mm-40 -129.34 151.47 49.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 4.9100000000000001 110.444 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.53 136.43 45.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.82 0.343 . . . . 4.6100000000000003 110.647 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 125' ' ' SER . 14.1 tp -63.77 151.17 42.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.626 0.727 . . . . 4.0300000000000002 111.587 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -127.14 152.68 47.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.581 -1.19 . . . . 5.1799999999999997 110.609 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -72.19 125.57 27.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 5.9299999999999997 110.318 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.36 23.85 35.62 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.782 -0.723 . . . . 5.3700000000000001 112.119 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 19.1 t0 -48.71 163.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.013 0.435 . . . . 4.5300000000000002 111.203 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -142.64 134.97 27.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.909 -0.587 . . . . 5.0800000000000001 110.747 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 110' ' ' TRP . 3.1 mt -115.49 128.51 72.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 3.02 111.0 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.453 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 10.7 m -103.68 141.4 36.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.513 . . . . 4.04 109.857 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.513 ' HB ' ' CE1' ' A' ' 88' ' ' HIS . 34.6 m -140.67 158.86 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.384 0.512 . . . . 2.5499999999999998 112.384 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.43 44.21 8.84 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.791 -0.64 . . . . 2.98 111.966 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.5 t -85.05 140.76 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.688 0.756 . . . . 4.8099999999999996 112.56 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.0 -40.77 0.84 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 109.686 -1.366 . . . . 4.7699999999999996 109.686 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.84 121.31 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.592 -0.804 . . . . 4.5499999999999998 109.041 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -49.94 -27.07 4.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.803 0.335 . . . . 6.0499999999999998 111.468 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.01 7.38 45.3 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.462 0.542 . . . . 5.25 112.462 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -130.06 26.99 5.17 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.361 0.875 . . . . 3.7599999999999998 113.361 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.484 HG12 ' HA ' ' A' ' 134' ' ' VAL . 4.3 mt -107.38 139.76 28.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.65 -0.705 . . . . 4.5800000000000001 111.147 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.09 134.56 52.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.158 -0.928 . . . . 3.6000000000000001 110.405 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.435 ' HB3' HG22 ' A' ' 40' ' ' THR . 40.0 t -110.07 150.81 28.04 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.606 0.717 . . . . 4.54 112.25 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -137.02 139.1 41.16 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.69 -1.141 . . . . 3.73 110.851 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.23 137.92 41.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.699 0.285 . . . . 4.9100000000000001 110.97 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.66 125.42 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 120.961 0.41 . . . . 4.1600000000000001 111.174 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.89 111.41 23.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 6.9299999999999997 110.527 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.448 HG12 ' CD2' ' A' ' 124' ' ' LEU . 3.2 mt -84.9 134.29 27.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 5.1600000000000001 111.754 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.76 116.06 16.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.933 -0.576 . . . . 6.4800000000000004 110.967 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.05 -37.41 82.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 6.5999999999999996 110.771 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -59.16 -45.05 92.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.089 -0.505 . . . . 8.1199999999999992 110.561 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.453 ' CE2' ' CD2' ' A' ' 155' ' ' LEU . 34.2 t80 -57.55 -44.12 84.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.864 -0.607 . . . . 5.25 110.829 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -61.58 -37.3 83.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.89 -0.596 . . . . 5.4699999999999998 110.853 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -47.29 73.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.455 . . . . 7.2400000000000002 110.773 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.06 -43.51 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 5.4299999999999997 110.561 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.453 ' CD2' ' CE2' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -60.28 -35.84 76.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.04 -0.527 . . . . 4.4900000000000002 110.584 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -57.87 -44.14 86.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 5.7199999999999998 110.505 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 159' ' ' LYS . 72.4 mt-30 -85.96 -24.51 26.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 7.25 110.668 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.67 -91.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.178 -0.464 . . . . 5.2599999999999998 111.665 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 157' ' ' GLN . 27.7 tttm -100.6 113.85 27.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.864 0.364 . . . . 8.2899999999999991 110.927 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.1 m -66.81 134.51 29.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 7.6500000000000004 111.048 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -57.11 -39.53 75.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 8.0600000000000005 111.033 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 56.68 100.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 11.359999999999999 110.842 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 22.5 mm -76.91 109.83 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 11.01 111.078 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.303 -0.856 . . . . 14.67 110.89 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' SER . . . . . 0.47 ' C ' ' HG ' ' B' ' 166' ' ' LEU . 1.6 m . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.67 0.271 . . . . 11.460000000000001 111.243 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.47 ' HG ' ' C ' ' B' ' 165' ' ' SER . 2.9 pp 44.33 -173.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.137 -0.483 . . . . 9.9800000000000004 111.687 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -154.47 39.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.373 -0.376 . . . . 9.2200000000000006 110.885 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.51 128.67 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 7.0599999999999996 111.1 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -55.29 103.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 4.8399999999999999 111.078 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -117.91 134.13 55.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 5.2699999999999996 111.101 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.95 163.91 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 5.6200000000000001 110.942 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -129.05 48.15 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 7.0800000000000001 111.149 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' THR . . . . . 0.403 ' O ' ' CZ ' ' B' ' 175' ' ' PHE . 37.9 p -104.68 48.4 0.84 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.055 -0.52 . . . . 8.8699999999999992 110.858 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' PHE . . . . . 0.439 ' O ' ' CG ' ' B' ' 175' ' ' PHE . 4.9 p90 41.32 43.91 2.2 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.078 -0.51 . . . . 12.029999999999999 111.804 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 5.8 m 40.91 76.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.859 -0.609 . . . . 12.24 111.814 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.245 -0.883 . . . . 14.23 110.875 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.838 0.351 . . . . 9.96 110.956 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.81 14.08 9.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 10.84 111.327 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -47.24 50.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.817 0.341 . . . . 12.49 110.991 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -67.1 -52.35 43.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 10.44 110.935 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.41 -35.48 70.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 7.13 110.252 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 19' ' ' LEU . 6.7 mt -58.08 -35.42 71.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.518 . . . . 10.01 110.005 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HA ' ' CD2' ' A' ' 23' ' ' PHE . 4.1 mt -64.32 -48.18 86.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.88 -0.6 . . . . 9.26 110.142 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.67 -33.39 72.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.402 -0.817 . . . . 6.87 111.074 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -64.72 -46.66 81.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 8.31 111.982 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.491 ' CG ' ' N ' ' A' ' 24' ' ' SER . 1.6 p90 -71.21 -48.86 48.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.949 0.404 . . . . 12.56 111.143 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.491 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 3.7 m -58.08 -38.03 75.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.832 -0.622 . . . . 10.54 110.791 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 179.15 88.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 10.75 110.944 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.63 154.93 27.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 10.66 110.363 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.99 100.4 2.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.382 . . . . 8.4 110.662 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.55 HG22 HD21 ' A' ' 148' ' ' ASN . 13.3 mm -105.58 140.46 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.559 0.695 . . . . 8.22 111.838 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.93 -0.05 9.08 Favored Glycine 0 C--N 1.316 -0.554 0 CA-C-N 114.775 -1.102 . . . . 7.28 112.915 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.36 -35.91 40.74 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.968 0.413 . . . . 8.8 110.64 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.1 m-20 -177.19 32.94 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.977 -1.12 . . . . 6.31 107.977 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.507 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 10.6 mm -90.84 120.26 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 CA-C-N 113.813 -1.539 . . . . 5.95 111.47 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.088 HG23 ' HA ' ' A' ' 49' ' ' SER . 1.9 t -85.58 -66.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 115.135 -0.939 . . . . 4.17 110.953 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.559 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.8 p -147.72 157.56 43.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.892 -0.594 . . . . 3.82 110.838 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.412 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -119.94 138.17 53.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.333 -0.394 . . . . 7.13 111.068 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -106.4 122.68 60.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.855 0.36 . . . . 4.4 111.148 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.859 HG23 HG12 ' A' ' 45' ' ' ILE . 20.1 mt -127.07 124.05 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.077 -0.51 . . . . 5.6 111.492 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.76 ' HA ' HD13 ' A' ' 143' ' ' LEU . 44.2 t -81.19 124.82 29.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.555 -0.293 . . . . 5.24 110.555 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.14 -25.88 18.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.453 -0.339 . . . . 5.77 111.516 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.455 HG23 ' HB3' ' A' ' 142' ' ' SER . 64.3 p -79.82 -2.57 43.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 5.14 111.468 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.93 74.8 0.41 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.982 -0.628 . . . . 5.41 113.095 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.425 ' CB ' HD11 ' A' ' 141' ' ' LEU . 0.9 OUTLIER -145.38 -42.57 0.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 4.79 111.044 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.611 ' CD1' HD22 ' A' ' 78' ' ' LEU . 2.5 mt -115.45 140.86 26.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 4.91 110.897 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.3 Cg_endo -72.53 143.72 38.9 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.155 1.903 . . . . 5.97 112.164 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.859 HG12 HG23 ' A' ' 37' ' ' ILE . 34.8 mt -58.09 143.43 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 6.44 111.634 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -135.94 164.1 28.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.643 -0.708 . . . . 6.42 109.991 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.4 m-20 -119.86 119.55 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 6.5 111.925 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.616 HD22 ' CD1' ' A' ' 66' ' ' TRP . 4.2 mt -92.73 137.07 32.68 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.881 -0.785 . . . . 4.31 108.881 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 1.088 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -149.49 158.31 44.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 114.198 1.185 . . . . 5.29 114.198 -178.696 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.77 146.26 32.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.635 -1.62 . . . . 4.61 111.053 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.909 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -74.83 125.85 29.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.228 -0.442 . . . . 6.64 111.181 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.745 HD13 ' SG ' ' A' ' 154' ' ' CYS . 46.5 mt -64.57 -42.04 94.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.801 -0.636 . . . . 4.99 112.016 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 71.8 m -61.66 -39.93 93.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.339 0.59 . . . . 6.07 110.526 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 24.8 mm-40 -69.22 -36.82 77.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.124 -0.944 . . . . 6.63 110.752 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 51' ' ' ASP . 49.4 t -66.68 -45.57 87.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.04 -0.527 . . . . 4.34 110.884 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 159' ' ' LYS . 4.4 tt -71.08 -41.33 70.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 4.46 110.802 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -69.27 -37.63 77.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 7.88 110.753 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -82.04 100.09 9.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.201 -0.454 . . . . 5.64 110.878 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.04 46.54 1.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 6.68 110.861 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -169.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 8.57 110.868 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.8 m -67.44 -51.62 49.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 5.24 111.009 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 93' ' ' LEU . 9.8 tp -130.45 157.18 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 4.26 111.219 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.713 ' HG2' HG13 ' A' ' 55' ' ' VAL . 9.3 mptt -103.49 -78.44 0.55 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.295 -0.411 . . . . 4.22 111.109 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 49' ' ' SER . 8.1 ttpt -128.09 136.2 50.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.398 -0.364 . . . . 4.99 111.266 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.615 HG12 ' HG2' ' A' ' 90' ' ' GLN . 5.7 t -125.72 138.64 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.074 0.464 . . . . 3.44 111.668 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.616 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.9 m-90 -101.54 139.38 37.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.522 -0.763 . . . . 3.66 112.127 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.66 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.73 126.92 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.149 -0.685 . . . . 3.54 109.149 177.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -115.51 145.54 42.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.103 -0.499 . . . . 2.49 111.271 -178.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.02 -168.04 36.21 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.576 -0.821 . . . . 3.33 112.709 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 4.1 mtp-105 -83.43 4.2 28.69 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.665 0.246 . . . . 4.7 111.665 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.619 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 8.7 t-20 -84.87 133.66 43.07 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.653 0.263 . . . . 5.4 111.195 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.6 Cg_exo -67.3 -12.87 37.44 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.642 2.228 . . . . 6.09 111.779 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.619 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -84.02 -42.79 15.8 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.849 0.833 . . . . 5.58 109.051 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.56 136.33 1.87 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.821 -1.536 . . . . 4.62 111.178 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.9 m-20 -55.61 -18.42 7.66 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.527 -0.76 . . . . 4.99 109.992 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 29.5 t80 -130.74 116.06 17.5 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.375 -0.375 . . . . 3.95 110.543 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -99.77 118.97 37.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.895 0.379 . . . . 5.42 111.042 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.611 HD22 ' CD1' ' A' ' 43' ' ' ILE . 2.9 mt -87.11 -167.35 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 4.29 110.614 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.44 -76.49 0.92 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.699 -0.762 . . . . 4.49 112.339 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.45 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 0.6 OUTLIER 175.11 78.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 5.14 110.81 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.427 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 30.8 mm -110.11 111.3 35.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 3.05 111.311 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 m -55.08 -30.15 59.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 3.52 111.197 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.39 -31.35 70.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.398 -0.365 . . . . 3.96 110.862 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.623 HD21 HG23 ' A' ' 132' ' ' VAL . 35.3 mt -88.22 152.01 22.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 2.76 110.715 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 p -96.2 160.51 14.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.773 0.286 . . . . 3.11 111.773 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.618 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -38.01 -53.28 1.37 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.368 0.604 . . . . 4.79 110.001 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.43 ' HB3' HG22 ' A' ' 67' ' ' THR . 8.1 mttt -119.71 83.01 1.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.988 -1.486 . . . . 4.87 106.988 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -62.11 -46.17 90.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.115 -0.948 . . . . 2.31 112.728 -177.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.7 p90 -145.77 161.34 40.16 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.26 -0.576 . . . . 1.88 111.913 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.66 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.6 tt0 -136.23 142.32 44.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.21 -0.45 . . . . 3.38 111.407 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.539 ' O ' HG13 ' A' ' 65' ' ' VAL . 60.9 mt -117.33 132.15 67.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 121.109 -0.236 . . . . 2.07 110.891 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.448 HD11 HD13 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -112.57 143.1 44.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.031 0.443 . . . . 2.85 111.853 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.792 HD13 ' CG1' ' A' ' 33' ' ' VAL . 11.0 tp -125.27 128.46 48.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.796 -0.638 . . . . 2.99 110.387 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.07 -129.19 1.98 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.586 -0.816 . . . . 2.79 112.557 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.3 -76.25 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.765 0.316 . . . . 5.65 110.934 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -158.38 -68.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 4.45 110.962 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.489 ' HA2' HD12 ' A' ' 155' ' ' LEU . . . -148.63 28.37 1.32 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.704 -0.76 . . . . 3.67 112.469 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -132.06 -178.06 4.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 3.8 110.894 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.85 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -125.48 155.35 40.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 2.8 110.87 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.895 HD22 ' HB3' ' A' ' 121' ' ' ASN . 2.3 mt -133.19 146.65 51.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 3.34 110.357 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.513 HD21 ' CD1' ' A' ' 130' ' ' ILE . 0.8 OUTLIER -112.7 127.82 56.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.331 -0.395 . . . . 2.97 110.346 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 51.0 t30 -118.16 115.2 24.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 3.36 111.682 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.833 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.1 p30 -77.16 142.89 39.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.209 -0.45 . . . . 3.75 109.919 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 67' ' ' THR . 11.9 pt -150.26 38.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.028 0.381 . . . . 3.16 112.028 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.588 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.51 153.63 18.88 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 120.996 0.427 . . . . 3.64 111.576 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.691 HG22 ' HB2' ' B' ' 171' ' ' ALA . 99.1 m -69.83 -32.11 70.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.849 -0.614 . . . . 4.36 109.969 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -95.72 -20.67 18.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.824 0.675 . . . . 4.07 112.824 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.588 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.99 158.27 10.88 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.395 -0.907 . . . . 3.48 113.357 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.6 m -117.86 138.55 52.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.555 -0.535 . . . . 3.48 109.555 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.884 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.48 149.05 40.16 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.598 0.962 . . . . 4.71 113.598 -178.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.38 112.17 16.63 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.671 -1.149 . . . . 4.8 108.35 177.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 44.72 43.21 6.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 5.68 112.258 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.17 -11.56 69.11 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.779 -0.724 . . . . 5.6 113.483 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -104.64 117.32 33.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.149 0.474 . . . . 6.58 110.789 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.884 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.3 tptm -72.29 131.44 42.7 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.866 -0.606 . . . . 5.37 111.217 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.833 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.0 m -103.44 165.36 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 4.63 111.308 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' SER . 37.3 tt0 -69.71 125.79 27.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 6.9 110.671 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.675 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.9 tttt -53.32 162.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.369 . . . . 4.73 110.784 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASP . 11.0 m-80 33.89 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.571 -0.74 . . . . 5.13 112.351 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -113.67 144.97 42.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.717 -0.674 . . . . 5.02 111.01 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.895 ' HB3' HD22 ' A' ' 100' ' ' LEU . 5.5 m-80 -86.66 134.8 33.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 4.47 110.934 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.86 ' O ' HD23 ' A' ' 100' ' ' LEU . 39.5 mm-40 -129.34 151.47 49.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 4.63 110.444 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.53 136.43 45.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.82 0.343 . . . . 4.28 110.647 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.921 HD21 HG12 ' A' ' 147' ' ' ILE . 14.1 tp -63.77 151.17 42.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.626 0.727 . . . . 3.83 111.587 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.769 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -127.14 152.68 47.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.581 -1.19 . . . . 4.97 110.609 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.539 ' HA ' HD12 ' A' ' 147' ' ' ILE . 4.8 mm100 -72.19 125.57 27.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 5.93 110.318 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.36 23.85 35.62 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.782 -0.723 . . . . 4.98 112.119 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 19.1 t0 -48.71 163.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.013 0.435 . . . . 4.38 111.203 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.507 ' HG3' HG22 ' A' ' 144' ' ' VAL . 29.3 tt0 -142.64 134.97 27.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.909 -0.587 . . . . 5.08 110.747 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.513 ' CD1' HD21 ' A' ' 101' ' ' LEU . 3.1 mt -115.49 128.51 72.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 3.02 111.0 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.536 HG22 ' CG2' ' A' ' 140' ' ' ILE . 10.7 m -103.68 141.4 36.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.513 . . . . 3.74 109.857 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.623 HG23 HD21 ' A' ' 84' ' ' LEU . 34.6 m -140.67 158.86 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.384 0.512 . . . . 2.51 112.384 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.43 44.21 8.84 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.791 -0.64 . . . . 2.98 111.966 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.5 t -85.05 140.76 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.688 0.756 . . . . 4.36 112.56 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.0 -40.77 0.84 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 109.686 -1.366 . . . . 4.77 109.686 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 138' ' ' SER . 48.6 t -126.84 121.31 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.592 -0.804 . . . . 4.26 109.041 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.455 ' HA ' HD12 ' A' ' 140' ' ' ILE . 14.2 tt0 -49.94 -27.07 4.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.803 0.335 . . . . 6.05 111.468 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.591 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -94.01 7.38 45.3 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.462 0.542 . . . . 4.92 112.462 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -130.06 26.99 5.17 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.361 0.875 . . . . 3.61 113.361 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.536 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.3 mt -107.38 139.76 28.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.65 -0.705 . . . . 4.22 111.147 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -125.09 134.56 52.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.158 -0.928 . . . . 3.19 110.405 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.584 ' C ' HD22 ' A' ' 143' ' ' LEU . 40.0 t -110.07 150.81 28.04 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.606 0.717 . . . . 4.19 112.25 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.6 mm? -137.02 139.1 41.16 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.69 -1.141 . . . . 3.38 110.851 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.507 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.2 t -111.23 137.92 41.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.699 0.285 . . . . 4.72 110.97 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.437 HD11 HD11 ' A' ' 101' ' ' LEU . 6.1 mt -105.66 125.42 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 120.961 0.41 . . . . 4.16 111.174 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.89 111.41 23.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 6.45 110.527 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.921 HG12 HD21 ' A' ' 124' ' ' LEU . 3.2 mt -84.9 134.29 27.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 5.16 111.754 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.55 HD21 HG22 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -75.76 116.06 16.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.933 -0.576 . . . . 6.13 110.967 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.05 -37.41 82.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 6.36 110.771 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -59.16 -45.05 92.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.089 -0.505 . . . . 7.77 110.561 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.648 ' CE2' HD23 ' A' ' 155' ' ' LEU . 34.2 t80 -57.55 -44.12 84.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.864 -0.607 . . . . 5.21 110.829 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -61.58 -37.3 83.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.89 -0.596 . . . . 5.19 110.853 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -47.29 73.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.455 . . . . 6.99 110.773 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.745 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.7 t -64.06 -43.51 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 5.32 110.561 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.648 HD23 ' CE2' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -60.28 -35.84 76.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.04 -0.527 . . . . 4.46 110.584 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -57.87 -44.14 86.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 5.72 110.505 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 159' ' ' LYS . 72.4 mt-30 -85.96 -24.51 26.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 6.84 110.668 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.67 -91.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.178 -0.464 . . . . 5.26 111.665 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.669 ' HB2' HD11 ' A' ' 56' ' ' LEU . 27.7 tttm -100.6 113.85 27.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.864 0.364 . . . . 8.06 110.927 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.1 m -66.81 134.51 29.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 7.19 111.048 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -57.11 -39.53 75.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 8.06 111.033 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 56.68 100.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 10.85 110.842 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 22.5 mm -76.91 109.83 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 10.77 111.078 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.303 -0.856 . . . . 14.17 110.89 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' SER . . . . . 0.495 ' C ' ' HG ' ' B' ' 166' ' ' LEU . 1.6 m . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.67 0.271 . . . . 11.45 111.243 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.511 HD13 HG23 ' B' ' 168' ' ' VAL . 2.9 pp 44.33 -173.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.137 -0.483 . . . . 9.62 111.687 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -154.47 39.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.373 -0.376 . . . . 9.22 110.885 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.511 HG23 HD13 ' B' ' 166' ' ' LEU . 21.6 t -57.51 128.67 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 6.56 111.1 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -55.29 103.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 4.33 111.078 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.691 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -117.91 134.13 55.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 5.27 111.101 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.95 163.91 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 5.51 110.942 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -129.05 48.15 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 7.08 111.149 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' THR . . . . . 0.544 ' O ' ' HZ ' ' B' ' 175' ' ' PHE . 37.9 p -104.68 48.4 0.84 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.055 -0.52 . . . . 8.87 110.858 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 175' ' ' PHE . . . . . 0.544 ' HZ ' ' O ' ' B' ' 174' ' ' THR . 4.9 p90 41.32 43.91 2.2 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.078 -0.51 . . . . 11.38 111.804 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 5.8 m 40.91 76.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.859 -0.609 . . . . 11.95 111.814 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.245 -0.883 . . . . 14.01 110.875 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.838 0.351 . . . . 9.96 110.956 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.81 14.08 9.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.52 . . . . 10.84 111.327 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -47.24 50.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.817 0.341 . . . . 12.49 110.991 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -67.1 -52.35 43.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 10.44 110.935 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.41 -35.48 70.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 7.13 110.252 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 19' ' ' LEU . 6.7 mt -58.08 -35.42 71.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.518 . . . . 10.01 110.005 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HA ' ' CD2' ' A' ' 23' ' ' PHE . 4.1 mt -64.32 -48.18 86.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.88 -0.6 . . . . 9.26 110.142 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -69.67 -33.39 72.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.402 -0.817 . . . . 6.87 111.074 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -64.72 -46.66 81.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 8.31 111.982 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.491 ' CG ' ' N ' ' A' ' 24' ' ' SER . 1.6 p90 -71.21 -48.86 48.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.949 0.404 . . . . 12.56 111.143 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.491 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 3.7 m -58.08 -38.03 75.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.832 -0.622 . . . . 10.54 110.791 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 179.15 88.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 10.75 110.944 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.63 154.93 27.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 10.66 110.363 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.99 100.4 2.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.382 . . . . 8.4 110.662 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.55 HG22 HD21 ' A' ' 148' ' ' ASN . 13.3 mm -105.58 140.46 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 CA-C-O 121.559 0.695 . . . . 8.22 111.838 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.93 -0.05 9.08 Favored Glycine 0 C--N 1.316 -0.554 0 CA-C-N 114.775 -1.102 . . . . 7.28 112.915 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.36 -35.91 40.74 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.968 0.413 . . . . 8.8 110.64 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 49' ' ' SER . 2.1 m-20 -177.19 32.94 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.977 -1.12 . . . . 6.31 107.977 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.507 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 10.6 mm -90.84 120.26 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.859 0 CA-C-N 113.813 -1.539 . . . . 5.95 111.47 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.088 HG23 ' HA ' ' A' ' 49' ' ' SER . 1.9 t -85.58 -66.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 115.135 -0.939 . . . . 4.17 110.953 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.559 ' SG ' HD12 ' A' ' 48' ' ' LEU . 3.8 p -147.72 157.56 43.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.892 -0.594 . . . . 3.82 110.838 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.412 ' HG2' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -119.94 138.17 53.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.333 -0.394 . . . . 7.13 111.068 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -106.4 122.68 60.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.855 0.36 . . . . 4.4 111.148 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.859 HG23 HG12 ' A' ' 45' ' ' ILE . 20.1 mt -127.07 124.05 63.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.077 -0.51 . . . . 5.6 111.492 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.76 ' HA ' HD13 ' A' ' 143' ' ' LEU . 44.2 t -81.19 124.82 29.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.555 -0.293 . . . . 5.24 110.555 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.14 -25.88 18.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.453 -0.339 . . . . 5.77 111.516 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.455 HG23 ' HB3' ' A' ' 142' ' ' SER . 64.3 p -79.82 -2.57 43.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 5.14 111.468 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.93 74.8 0.41 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.982 -0.628 . . . . 5.41 113.095 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.425 ' CB ' HD11 ' A' ' 141' ' ' LEU . 7.8 mt-30 -145.38 -42.57 0.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 4.79 111.044 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.611 ' CD1' HD22 ' A' ' 78' ' ' LEU . 2.5 mt -115.45 140.86 26.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 4.91 110.897 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 55.3 Cg_endo -72.53 143.72 38.9 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.155 1.903 . . . . 5.97 112.164 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.859 HG12 HG23 ' A' ' 37' ' ' ILE . 34.8 mt -58.09 143.43 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 6.44 111.634 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -135.94 164.1 28.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.643 -0.708 . . . . 6.42 109.991 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 35' ' ' ARG . 1.4 m-20 -119.86 119.55 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 6.5 111.925 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.616 HD22 ' CD1' ' A' ' 66' ' ' TRP . 4.2 mt -92.73 137.07 32.68 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.881 -0.785 . . . . 4.31 108.881 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 1.088 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -149.49 158.31 44.06 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 114.198 1.185 . . . . 5.29 114.198 -178.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -144.77 146.26 32.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.635 -1.62 . . . . 4.61 111.053 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.909 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -74.83 125.85 29.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.228 -0.442 . . . . 6.64 111.181 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.745 HD13 ' SG ' ' A' ' 154' ' ' CYS . 46.5 mt -64.57 -42.04 94.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.801 -0.636 . . . . 4.99 112.016 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 71.8 m -61.66 -39.93 93.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.339 0.59 . . . . 6.07 110.526 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 24.8 mm-40 -69.22 -36.82 77.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.124 -0.944 . . . . 6.63 110.752 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 51' ' ' ASP . 49.4 t -66.68 -45.57 87.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.04 -0.527 . . . . 4.34 110.884 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 159' ' ' LYS . 4.4 tt -71.08 -41.33 70.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 4.46 110.802 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -69.27 -37.63 77.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 7.88 110.753 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -82.04 100.09 9.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.201 -0.454 . . . . 5.64 110.878 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.04 46.54 1.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 6.68 110.861 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.69 -169.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 8.57 110.868 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.8 m -67.44 -51.62 49.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 5.24 111.009 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 93' ' ' LEU . 9.8 tp -130.45 157.18 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 4.26 111.219 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.713 ' HG2' HG13 ' A' ' 55' ' ' VAL . 9.3 mptt -103.49 -78.44 0.55 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.295 -0.411 . . . . 4.22 111.109 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' CE ' ' O ' ' A' ' 49' ' ' SER . 8.1 ttpt -128.09 136.2 50.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.398 -0.364 . . . . 4.99 111.266 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.615 HG12 ' HG2' ' A' ' 90' ' ' GLN . 5.7 t -125.72 138.64 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.074 0.464 . . . . 3.44 111.668 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.616 ' CD1' HD22 ' A' ' 48' ' ' LEU . 15.9 m-90 -101.54 139.38 37.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.522 -0.763 . . . . 3.66 112.127 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.66 HG23 ' HG3' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -113.73 126.92 55.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.149 -0.685 . . . . 3.54 109.149 177.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.599 ' CE2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -115.51 145.54 42.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.103 -0.499 . . . . 2.49 111.271 -178.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 86' ' ' ASN . . . 161.02 -168.04 36.21 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.576 -0.821 . . . . 3.33 112.709 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 81' ' ' ILE . 4.1 mtp-105 -83.43 4.2 28.69 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.665 0.246 . . . . 4.7 111.665 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.619 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 8.7 t-20 -84.87 133.66 43.07 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.653 0.263 . . . . 5.4 111.195 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 15.6 Cg_exo -67.3 -12.87 37.44 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.642 2.228 . . . . 6.09 111.779 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.619 ' HB3' ' OD1' ' A' ' 71' ' ' ASN . . . -84.02 -42.79 15.8 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.849 0.833 . . . . 5.58 109.051 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -41.56 136.33 1.87 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.821 -1.536 . . . . 4.62 111.178 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.9 m-20 -55.61 -18.42 7.66 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.527 -0.76 . . . . 4.99 109.992 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 29.5 t80 -130.74 116.06 17.5 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.375 -0.375 . . . . 3.95 110.543 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -99.77 118.97 37.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.895 0.379 . . . . 5.42 111.042 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.611 HD22 ' CD1' ' A' ' 43' ' ' ILE . 2.9 mt -87.11 -167.35 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 4.29 110.614 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.44 -76.49 0.92 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.699 -0.762 . . . . 4.49 112.339 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 p30 175.11 78.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 5.14 110.81 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.427 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 30.8 mm -110.11 111.3 35.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 3.05 111.311 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 m -55.08 -30.15 59.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 3.52 111.197 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.39 -31.35 70.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.398 -0.365 . . . . 3.96 110.862 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.623 HD21 HG23 ' A' ' 132' ' ' VAL . 35.3 mt -88.22 152.01 22.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 2.76 110.715 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.6 p -96.2 160.51 14.39 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.773 0.286 . . . . 3.11 111.773 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.618 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 3.1 m-20 -38.01 -53.28 1.37 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.368 0.604 . . . . 4.79 110.001 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.43 ' HB3' HG22 ' A' ' 67' ' ' THR . 8.1 mttt -119.71 83.01 1.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.988 -1.486 . . . . 4.87 106.988 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.551 ' CE1' ' HB3' ' A' ' 105' ' ' SER . 12.9 t60 -62.11 -46.17 90.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.115 -0.948 . . . . 2.31 112.728 -177.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE2' ' CG ' ' A' ' 68' ' ' PHE . 27.7 p90 -145.77 161.34 40.16 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.26 -0.576 . . . . 1.88 111.913 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.66 ' HG3' HG23 ' A' ' 67' ' ' THR . 4.6 tt0 -136.23 142.32 44.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.21 -0.45 . . . . 3.38 111.407 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.539 ' O ' HG13 ' A' ' 65' ' ' VAL . 60.9 mt -117.33 132.15 67.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 121.109 -0.236 . . . . 2.07 110.891 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.448 HD11 HD13 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -112.57 143.1 44.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.031 0.443 . . . . 2.85 111.853 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.792 HD13 ' CG1' ' A' ' 33' ' ' VAL . 11.0 tp -125.27 128.46 48.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.796 -0.638 . . . . 2.99 110.387 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.07 -129.19 1.98 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.586 -0.816 . . . . 2.79 112.557 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.3 -76.25 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.765 0.316 . . . . 5.65 110.934 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -158.38 -68.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 4.45 110.962 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.489 ' HA2' HD12 ' A' ' 155' ' ' LEU . . . -148.63 28.37 1.32 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.704 -0.76 . . . . 3.67 112.469 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -132.06 -178.06 4.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 3.8 110.894 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.85 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -125.48 155.35 40.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 2.8 110.87 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.895 HD22 ' HB3' ' A' ' 121' ' ' ASN . 2.3 mt -133.19 146.65 51.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 3.34 110.357 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.513 HD21 ' CD1' ' A' ' 130' ' ' ILE . 0.8 OUTLIER -112.7 127.82 56.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.331 -0.395 . . . . 2.97 110.346 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' HB2' ' CD2' ' A' ' 92' ' ' LEU . 51.0 t30 -118.16 115.2 24.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.393 . . . . 3.36 111.682 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.833 ' OD2' HG23 ' A' ' 116' ' ' VAL . 9.1 p30 -77.16 142.89 39.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.209 -0.45 . . . . 3.75 109.919 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 67' ' ' THR . 11.9 pt -150.26 38.69 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.028 0.381 . . . . 3.16 112.028 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.588 ' HB2' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -99.51 153.63 18.88 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 120.996 0.427 . . . . 3.64 111.576 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.691 HG22 ' HB2' ' B' ' 171' ' ' ALA . 99.1 m -69.83 -32.11 70.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.849 -0.614 . . . . 4.36 109.969 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -95.72 -20.67 18.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 112.824 0.675 . . . . 4.07 112.824 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.588 ' H ' ' HB2' ' A' ' 105' ' ' SER . . . 117.99 158.27 10.88 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.395 -0.907 . . . . 3.48 113.357 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 11.6 m -117.86 138.55 52.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.555 -0.535 . . . . 3.48 109.555 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.884 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -116.48 149.05 40.16 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.598 0.962 . . . . 4.71 113.598 -178.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -124.38 112.17 16.63 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.671 -1.149 . . . . 4.8 108.35 177.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 44.72 43.21 6.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 5.68 112.258 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.17 -11.56 69.11 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.779 -0.724 . . . . 5.6 113.483 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -104.64 117.32 33.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.149 0.474 . . . . 6.58 110.789 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.884 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 11.3 tptm -72.29 131.44 42.7 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.866 -0.606 . . . . 5.37 111.217 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.833 HG23 ' OD2' ' A' ' 103' ' ' ASP . 14.0 m -103.44 165.36 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.984 -0.553 . . . . 4.63 111.308 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' SER . 37.3 tt0 -69.71 125.79 27.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 6.9 110.671 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.675 ' HA ' ' CG ' ' A' ' 103' ' ' ASP . 80.9 tttt -53.32 162.57 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.369 . . . . 4.73 110.784 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 103' ' ' ASP . 11.0 m-80 33.89 34.66 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.571 -0.74 . . . . 5.13 112.351 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -113.67 144.97 42.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.717 -0.674 . . . . 5.02 111.01 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.895 ' HB3' HD22 ' A' ' 100' ' ' LEU . 7.5 m120 -86.66 134.8 33.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 4.47 110.934 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.86 ' O ' HD23 ' A' ' 100' ' ' LEU . 39.5 mm-40 -129.34 151.47 49.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 4.63 110.444 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.53 136.43 45.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.82 0.343 . . . . 4.28 110.647 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.921 HD21 HG12 ' A' ' 147' ' ' ILE . 14.1 tp -63.77 151.17 42.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.626 0.727 . . . . 3.83 111.587 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.769 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.4 OUTLIER -127.14 152.68 47.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.581 -1.19 . . . . 4.97 110.609 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.539 ' HA ' HD12 ' A' ' 147' ' ' ILE . 1.6 mm-40 -72.19 125.57 27.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 5.93 110.318 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.36 23.85 35.62 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.782 -0.723 . . . . 4.98 112.119 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 19.1 t0 -48.71 163.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.013 0.435 . . . . 4.38 111.203 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.507 ' HG3' HG22 ' A' ' 144' ' ' VAL . 29.3 tt0 -142.64 134.97 27.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.909 -0.587 . . . . 5.08 110.747 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.513 ' CD1' HD21 ' A' ' 101' ' ' LEU . 3.1 mt -115.49 128.51 72.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 3.02 111.0 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.536 HG22 ' CG2' ' A' ' 140' ' ' ILE . 10.7 m -103.68 141.4 36.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.513 . . . . 3.74 109.857 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.623 HG23 HD21 ' A' ' 84' ' ' LEU . 34.6 m -140.67 158.86 24.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.384 0.512 . . . . 2.51 112.384 -178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.43 44.21 8.84 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.791 -0.64 . . . . 2.98 111.966 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 140' ' ' ILE . 54.5 t -85.05 140.76 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.688 0.756 . . . . 4.36 112.56 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.0 -40.77 0.84 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 109.686 -1.366 . . . . 4.77 109.686 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 138' ' ' SER . 48.6 t -126.84 121.31 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.592 -0.804 . . . . 4.26 109.041 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.455 ' HA ' HD12 ' A' ' 140' ' ' ILE . 14.2 tt0 -49.94 -27.07 4.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.803 0.335 . . . . 6.05 111.468 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.591 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -94.01 7.38 45.3 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.462 0.542 . . . . 4.92 112.462 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -130.06 26.99 5.17 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.361 0.875 . . . . 3.61 113.361 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.536 ' CG2' HG22 ' A' ' 131' ' ' THR . 4.3 mt -107.38 139.76 28.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.65 -0.705 . . . . 4.22 111.147 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -125.09 134.56 52.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.158 -0.928 . . . . 3.19 110.405 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.584 ' C ' HD22 ' A' ' 143' ' ' LEU . 40.0 t -110.07 150.81 28.04 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.606 0.717 . . . . 4.19 112.25 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' A' ' 38' ' ' CYS . 2.6 mm? -137.02 139.1 41.16 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.69 -1.141 . . . . 3.38 110.851 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.507 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.2 t -111.23 137.92 41.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.699 0.285 . . . . 4.72 110.97 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.437 HD11 HD11 ' A' ' 101' ' ' LEU . 6.1 mt -105.66 125.42 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 120.961 0.41 . . . . 4.16 111.174 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.89 111.41 23.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 6.45 110.527 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.921 HG12 HD21 ' A' ' 124' ' ' LEU . 3.2 mt -84.9 134.29 27.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 5.16 111.754 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.55 HD21 HG22 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -75.76 116.06 16.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.933 -0.576 . . . . 6.13 110.967 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.05 -37.41 82.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 6.36 110.771 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -59.16 -45.05 92.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.089 -0.505 . . . . 7.77 110.561 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.648 ' CE2' HD23 ' A' ' 155' ' ' LEU . 34.2 t80 -57.55 -44.12 84.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.864 -0.607 . . . . 5.21 110.829 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -61.58 -37.3 83.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.89 -0.596 . . . . 5.19 110.853 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -47.29 73.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.455 . . . . 6.99 110.773 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.745 ' SG ' HD13 ' A' ' 52' ' ' ILE . 9.7 t -64.06 -43.51 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 5.32 110.561 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.648 HD23 ' CE2' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -60.28 -35.84 76.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.04 -0.527 . . . . 4.46 110.584 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -57.87 -44.14 86.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 5.72 110.505 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 159' ' ' LYS . 72.4 mt-30 -85.96 -24.51 26.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 6.84 110.668 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.67 -91.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.178 -0.464 . . . . 5.26 111.665 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.669 ' HB2' HD11 ' A' ' 56' ' ' LEU . 27.7 tttm -100.6 113.85 27.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.864 0.364 . . . . 8.06 110.927 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.1 m -66.81 134.51 29.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 7.19 111.048 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -57.11 -39.53 75.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 8.06 111.033 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 56.68 100.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 10.85 110.842 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 22.5 mm -76.91 109.83 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 10.77 111.078 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.303 -0.856 . . . . 14.17 110.89 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' SER . . . . . 0.495 ' C ' ' HG ' ' B' ' 166' ' ' LEU . 1.6 m . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.67 0.271 . . . . 11.45 111.243 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.511 HD13 HG23 ' B' ' 168' ' ' VAL . 2.9 pp 44.33 -173.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.137 -0.483 . . . . 9.62 111.687 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -154.47 39.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.373 -0.376 . . . . 9.22 110.885 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.511 HG23 HD13 ' B' ' 166' ' ' LEU . 21.6 t -57.51 128.67 18.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 6.56 111.1 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -55.29 103.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 4.33 111.078 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.691 ' HB2' HG22 ' A' ' 106' ' ' THR . . . -117.91 134.13 55.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 5.27 111.101 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.95 163.91 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 5.51 110.942 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -129.05 48.15 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 7.08 111.149 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . 0.544 ' O ' ' HZ ' ' B' ' 175' ' ' PHE . 37.9 p -104.68 48.4 0.84 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.055 -0.52 . . . . 8.87 110.858 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' PHE . . . . . 0.544 ' HZ ' ' O ' ' B' ' 174' ' ' THR . 4.9 p90 41.32 43.91 2.2 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.078 -0.51 . . . . 11.38 111.804 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 5.8 m 40.91 76.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.859 -0.609 . . . . 11.95 111.814 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.245 -0.883 . . . . 14.01 110.875 -179.997 . . . . . . . . 0 0 . 1 stop_ save_